134 related articles for article (PubMed ID: 16443880)
1. Serum lipids and the progression of nephropathy in type 1 diabetes.
Thomas MC; Rosengård-Bärlund M; Mills V; Rönnback M; Thomas S; Forsblom C; Cooper ME; Taskinen MR; Viberti G; Groop PH
Diabetes Care; 2006 Feb; 29(2):317-22. PubMed ID: 16443880
[TBL] [Abstract][Full Text] [Related]
2. Glycemic control, dyslipidemia and endothelial dysfunction in coexisted diabetes, hypertension and nephropathy.
Shahid SM; Nawab SN; Shaikh R; Mahboob T
Pak J Pharm Sci; 2012 Jan; 25(1):123-9. PubMed ID: 22186319
[TBL] [Abstract][Full Text] [Related]
3. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
[TBL] [Abstract][Full Text] [Related]
4. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
[TBL] [Abstract][Full Text] [Related]
5. [Lower levels of HDL2 cholesterol are associated with microalbuminuria in patients with type 1 diabetes].
Bulum T; Duvnjak L; Prkacin I
Acta Med Croatica; 2011; 65(3):243-50. PubMed ID: 22359892
[TBL] [Abstract][Full Text] [Related]
6. Microvascular disease: what does the UKPDS tell us about diabetic nephropathy?
Bilous R
Diabet Med; 2008 Aug; 25 Suppl 2():25-9. PubMed ID: 18717975
[TBL] [Abstract][Full Text] [Related]
7. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
Lewis EJ; Lewis JB
Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
[TBL] [Abstract][Full Text] [Related]
8. Different lipid variables predict incident coronary artery disease in patients with type 1 diabetes with or without diabetic nephropathy: the FinnDiane study.
Tolonen N; Forsblom C; Mäkinen VP; Harjutsalo V; Gordin D; Feodoroff M; Sandholm N; Thorn LM; Wadén J; Taskinen MR; Groop PH;
Diabetes Care; 2014 Aug; 37(8):2374-82. PubMed ID: 24879842
[TBL] [Abstract][Full Text] [Related]
9. Differential dyslipidemia associated with albuminuria in type 2 diabetic patients in Taiwan.
Tseng CH
Clin Biochem; 2009 Jul; 42(10-11):1019-24. PubMed ID: 19324028
[TBL] [Abstract][Full Text] [Related]
10. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.
Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
Kidney Int; 2003 Sep; 64(3):817-28. PubMed ID: 12911531
[TBL] [Abstract][Full Text] [Related]
11. Triglyceride-cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane Study.
Mäkinen VP; Soininen P; Kangas AJ; Forsblom C; Tolonen N; Thorn LM; Viikari J; Raitakari OT; Savolainen M; Groop PH; Ala-Korpela M;
J Intern Med; 2013 Apr; 273(4):383-95. PubMed ID: 23279644
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus.
Tan KCB; Cheung CL; Lee ACH; Lam JKY; Wong Y; Shiu SWM
Diabetologia; 2018 May; 61(5):1212-1219. PubMed ID: 29417184
[TBL] [Abstract][Full Text] [Related]
13. Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes.
Kazumi T; Hozumi T; Ishida Y; Ikeda Y; Kishi K; Hayakawa M; Yoshino G
Diabetes Care; 1999 Jul; 22(7):1176-80. PubMed ID: 10388985
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and control of dyslipidaemia among diabetic patients with microalbuminuria in a Chinese hospital.
Wang SH; Wang L; Zhou Y; Guo YJ; Yuan Y; Li FF; Huang Y; Xia WQ
Diab Vasc Dis Res; 2013 Mar; 10(2):169-78. PubMed ID: 22906862
[TBL] [Abstract][Full Text] [Related]
15. Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients.
Saraheimo M; Teppo AM; Forsblom C; Fagerudd J; Groop PH
Diabetologia; 2003 Oct; 46(10):1402-7. PubMed ID: 12928771
[TBL] [Abstract][Full Text] [Related]
16. Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study.
Bruno G; Merletti F; Biggeri A; Bargero G; Ferrero S; Pagano G; Cavallo Perin P;
Diabetes Care; 2003 Jul; 26(7):2150-5. PubMed ID: 12832328
[TBL] [Abstract][Full Text] [Related]
17. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
Adler AI; Stevens RJ; Manley SE; Bilous RW; Cull CA; Holman RR;
Kidney Int; 2003 Jan; 63(1):225-32. PubMed ID: 12472787
[TBL] [Abstract][Full Text] [Related]
18. Serum amyloid A and C-reactive protein levels may predict microalbuminuria and macroalbuminuria in newly diagnosed type 1 diabetic patients.
Overgaard AJ; McGuire JN; Hovind P; Parving HH; Rossing P; Pociot F
J Diabetes Complications; 2013; 27(1):59-63. PubMed ID: 22885250
[TBL] [Abstract][Full Text] [Related]
19. Plasma triglycerides predict incident albuminuria and progression of coronary artery calcification in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study.
Bjornstad P; Maahs DM; Wadwa RP; Pyle L; Rewers M; Eckel RH; Snell-Bergeon JK
J Clin Lipidol; 2014; 8(6):576-583. PubMed ID: 25499940
[TBL] [Abstract][Full Text] [Related]
20. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries.
Sacks FM; Hermans MP; Fioretto P; Valensi P; Davis T; Horton E; Wanner C; Al-Rubeaan K; Aronson R; Barzon I; Bishop L; Bonora E; Bunnag P; Chuang LM; Deerochanawong C; Goldenberg R; Harshfield B; Hernández C; Herzlinger-Botein S; Itoh H; Jia W; Jiang YD; Kadowaki T; Laranjo N; Leiter L; Miwa T; Odawara M; Ohashi K; Ohno A; Pan C; Pan J; Pedro-Botet J; Reiner Z; Rotella CM; Simo R; Tanaka M; Tedeschi-Reiner E; Twum-Barima D; Zoppini G; Carey VJ
Circulation; 2014 Mar; 129(9):999-1008. PubMed ID: 24352521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
